Plasma Cells, also known as effector B cells or antibody-producing cells, are a specialized type of immune cell derived from activated B lymphocytes. These cells play a pivotal role in the adaptive immune response by producing large quantities of antibodies, also called immunoglobulins, to recognize and neutralize specific pathogens such as bacteria, viruses, and toxins. Plasma cells are generated during the immune response when B cells encounter antigens, triggering their activation and differentiation. The differentiated plasma cells have a unique morphology, featuring an expanded endoplasmic reticulum to accommodate the increased synthesis of antibodies. The primary function of plasma cells is the secretion of antibodies tailored to bind with high specificity to the antigens that initiated their activation. Antibodies play various roles in immunity, such as neutralizing pathogens, facilitating their removal by other immune cells, and marking them for destruction. Plasma cells are short-lived, typically surviving for a few days to weeks. However, a subset of long-lived plasma cells, known as memory B cells, can persist for an extended period, providing long-term immunity upon re-exposure to the same pathogen. Immunohistochemical staining techniques, targeting specific proteins like CD138, help identify plasma cells in tissues and confirm their presence during immune responses. Elevated levels of plasma cells in certain tissues may indicate immune-related disorders, such as autoimmune diseases or plasma cell dyscrasias like multiple myeloma. Research on plasma cells is critical for understanding the dynamics of the immune response, vaccine development, and the pathogenesis of various immune-mediated diseases. Manipulating plasma cell activity holds potential for therapeutic interventions to enhance immunity or modulate inappropriate immune responses. In summary, plasma cells are key effectors of the adaptive immune response, producing antibodies to target and neutralize specific pathogens. Their short-lived nature, coupled with the presence of memory B cells, contributes to the immune system's ability to mount rapid and robust responses upon encountering familiar antigens.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy